Literature DB >> 21420382

Overexpression of HDAC1 induces cellular senescence by Sp1/PP2A/pRb pathway.

Jian-Ying Chuang1, Jan-Jong Hung.   

Abstract

Senescence is associated with decreased activities of DNA replication, protein synthesis, and cellular division, which can result in deterioration of cellular functions. Herein, we report that the growth and division of tumor cells were significantly repressed by overexpression of histone deacetylase (HDAC) 1 with the Tet-off induced system or transient transfection. In addition, HDAC1 overexpression led to senescence through both an accumulation of hypophosphorylated active retinoblastoma protein (pRb) and an increase in the protein level of protein phosphatase 2A catalytic subunit (PP2Ac). HDAC1 overexpression also increased the level of Sp1 deacetylation and elevated the interaction between Sp1 and p300, and subsequently that Sp1/p300 complex bound to the promoter of PP2Ac, thus leading to induction of PP2Ac expression. Similar results were obtained in the HDAC1-Tet-off stable clone. Taken together, these results indicate that HDAC1 overexpression restrained cell proliferation and induced premature senescence in cervical cancer cells through a novel Sp1/PP2A/pRb pathway.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21420382     DOI: 10.1016/j.bbrc.2011.03.068

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Sp1 phosphorylation by cyclin-dependent kinase 1/cyclin B1 represses its DNA-binding activity during mitosis in cancer cells.

Authors:  J-Y Chuang; S-A Wang; W-B Yang; H-C Yang; C-Y Hung; T-P Su; W-C Chang; J-J Hung
Journal:  Oncogene       Date:  2012-01-23       Impact factor: 9.867

2.  Critical review of non-histone human substrates of metal-dependent lysine deacetylases.

Authors:  Tasha B Toro; Terry J Watt
Journal:  FASEB J       Date:  2020-08-30       Impact factor: 5.191

Review 3.  Metabolism, longevity and epigenetics.

Authors:  Claudia Cosentino; Raul Mostoslavsky
Journal:  Cell Mol Life Sci       Date:  2013-03-07       Impact factor: 9.261

4.  Molecular, biological characterization and drug sensitivity of chidamide-resistant non-small cell lung cancer cells.

Authors:  Song'e Luo; Kai Ma; Hongxia Zhu; Shuren Wang; Mei Liu; Weina Zhang; Shufang Liang; Ningzhi Xu
Journal:  Oncol Lett       Date:  2017-09-26       Impact factor: 2.967

5.  Functional role of post-translational modifications of Sp1 in tumorigenesis.

Authors:  Wen-Chang Chang; Jan-Jong Hung
Journal:  J Biomed Sci       Date:  2012-11-14       Impact factor: 8.410

6.  PSG gene expression is up-regulated by lysine acetylation involving histone and nonhistone proteins.

Authors:  Soledad A Camolotto; Ana C Racca; Magali E Ridano; Susana Genti-Raimondi; Graciela M Panzetta-Dutari
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

7.  Age-associated callus senescent cells produce TGF-β1 that inhibits fracture healing in aged mice.

Authors:  Jiatong Liu; Jun Zhang; Xi Lin; Brendan F Boyce; Hengwei Zhang; Lianping Xing
Journal:  J Clin Invest       Date:  2022-04-15       Impact factor: 19.456

Review 8.  Epigenetic regulation of cardiac myocyte differentiation.

Authors:  Kyohei Oyama; Danny El-Nachef; Yiqiang Zhang; Patima Sdek; W Robb MacLellan
Journal:  Front Genet       Date:  2014-11-04       Impact factor: 4.599

9.  Pin1-mediated Sp1 phosphorylation by CDK1 increases Sp1 stability and decreases its DNA-binding activity during mitosis.

Authors:  Hang-Che Yang; Jian-Ying Chuang; Wen-Yih Jeng; Chia-I Liu; Andrew H-J Wang; Pei-Jung Lu; Wen-Chang Chang; Jan-Jong Hung
Journal:  Nucleic Acids Res       Date:  2014-11-14       Impact factor: 16.971

10.  Repression of class I transcription by cadmium is mediated by the protein phosphatase 2A.

Authors:  Lei Zhou; Gwenaëlle Le Roux; Cécile Ducrot; Stéphane Chédin; Jean Labarre; Michel Riva; Christophe Carles
Journal:  Nucleic Acids Res       Date:  2013-05-02       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.